help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2004-0397
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
19/10/2502    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakanishi, T.
Right arrow Articles by Tanaka, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakanishi, T.
Right arrow Articles by Tanaka, K.
Molecular Endocrinology 19 (10): 2502-2516
Copyright © 2005 by The Endocrine Society

Trialkyltin Compounds Bind Retinoid X Receptor to Alter Human Placental Endocrine Functions

Tsuyoshi Nakanishi, Jun-ichi Nishikawa, Youhei Hiromori, Hideaki Yokoyama, Mihoko Koyanagi, Shinri Takasuga, Jun-ichi Ishizaki, Mai Watanabe, Shun-ichi Isa, Naoki Utoguchi, Norio Itoh, Yutaka Kohno, Tsutomu Nishihara and Keiichi Tanaka

Department of Toxicology (T.N., Y.H., H.Y., M.K., S.T., J.I., M.W., S.I., N.I., K.T.) and Laboratory of Environmental Biochemistry (J.N., T.N.), Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871; Laboratory of Pharmaceutics (N.U.), School of Pharmaceutical Sciences, Teikyo University, Sagamiko, Kanagawa 199-0195; and Development Division (Y.K.), Fujisawa Pharmaceutical Co., Ltd., Osaka 532-8514, Japan

Address all correspondence and requests for reprints to: Dr. Tsuyoshi Nakanishi, Department of Toxicology, Graduate School of Pharmaceutical Sciences, Osaka University, 1–6, Yamadaoka Suita, Osaka 565-0871, Japan. E-mail: nakanishi{at}phs.osaka-u.ac.jp.

Retinoid X receptor (RXR) is a nuclear receptor that plays important and multiple roles in mammalian development and homeostasis. We previously reported that, in human choriocarcinoma cells, tributyltin chloride and triphenyltin hydroxide, which are typical environmental contaminants and cause masculinization in female mollusks, are potent stimulators of human chorionic gonadotropin production and aromatase activity, which play key endocrine functions in maintaining pregnancy and fetal development. However, the molecular mechanism through which these compounds stimulate these endocrine functions remains unclear. Our current study shows that trialkyltin compounds, including tributyltin chloride and triphenyltin hydroxide, function as RXR agonists. Trialkyltins directly bind to the ligand-binding domain of RXR with high affinity and function as transcriptional activators. Unlike the natural RXR ligand, 9-cis-retinoic acid, the activity of trialkyltins is RXR specific and does not activate the retinoic acid receptor pathway. In addition, trialkyltins activate RXR to stimulate the expression of a luciferase reporter gene containing the human placental promoter I.1 sequence of aromatase, suggesting that trialkyltins stimulate human placental endocrine functions through RXR-dependent signaling pathways. Therefore, our results suggest that activation of RXR may be a novel mechanism by which trialkyltins alter human endocrine functions.

NURSA Molecule Pages Link:

Nuclear Receptors:   RXRα  |  RXRβ  |  RXRγ
Ligands:   LGD 100268  |  Am 580  |  9-cis-Retinoic acid  |  15-Deoxy-Δ12 14 prostaglandin  |  Rosiglitazone



This article has been cited by other articles:


Home page
EndocrinologyHome page
X. Wu, T. Iguchi, N. Itoh, K. Okamoto, T. Takagi, K. Tanaka, and T. Nakanishi
Ascorbic Acid Transported by Sodium-Dependent Vitamin C Transporter 2 Stimulates Steroidogenesis in Human Choriocarcinoma Cells
Endocrinology, January 1, 2008; 149(1): 73 - 83.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Grun and B. Blumberg
Environmental Obesogens: Organotins and Endocrine Disruption via Nuclear Receptor Signaling
Endocrinology, June 1, 2006; 147(6): s50 - s55.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society